Clinical Trials Sponsored by National Cancer Institute, Lithuania

Total 22057 results

National Cancer Institute (NCI)

Completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Sarcoma | Neuroectodermal Tumors, Primitive, Peripheral | Neuroblastoma | Rhabdomyosarcoma-Embryonal | Rhabdomyosarcoma- Alveolar

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment

Cancer | Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Peritoneal Mesothelioma | Pleural Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

Cervical Neoplasia | HPV Infections

Costa Rica
National Cancer Institute (NCI)

Completed

Testing the FLASHE Survey

Survey | Interview | Cognitive Testing

United States
National Cancer Institute (NCI)

Completed

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

HPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post Vaccination

Uganda
National Cancer Institute (NCI)

Completed

Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India

Chronic Diseases

India
National Cancer Institute (NCI)

Completed

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Cervical Cancer | Anal Cancer | Vaginal Cancer | Oropharyngeal Cancer | Penile Cancer

United States
National Cancer Institute (NCI)

Completed

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas

Lymphoma | Cutaneous | T-Cell

United States
National Cancer Institute (NCI)

Completed

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Carcinoma, Hepatocellular | Hepatocellular Carcinoma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Withdrawn

In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma

Metastatic Melanoma
National Cancer Institute (NCI)

Completed

Genetic and Protein Profiling in Normal and Cancerous Breast Tissue

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Lymphoma | Follicular Lymphoma | B Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia

Inflammatory Breast Cancer

Egypt, Tunisia
National Cancer Institute (NCI)

Completed

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

HIV Infections | Acquired Immunodeficiency Syndrome | Lymphoma | Leukemia | Kaposi's Sarcoma | Tumor Virus Infection

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Evaluation of Blood Vessel Formation in Endocrine Tumors

Lesions

United States
National Cancer Institute (NCI)

Completed

Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial

Lymphoma | Hodgkin's Disease

United States
National Cancer Institute (NCI)

Completed

A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening

Cervical Intraepithelial Neoplasia | Human Papillomavirus

United States
National Cancer Institute (NCI)

Completed

Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research

Sarcoma | Alveolar Soft Part Sarcoma

United States
National Cancer Institute (NCI)

Withdrawn

ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Pharmacokinetic Studies Participation Survey

Relapsed Solid Tumors | Relapsed Leukemia | Relapsed Brain Tumors

United States
National Cancer Institute (NCI)

Completed

HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)

HIV

United States
National Cancer Institute (NCI)

Completed

In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients

Cell Function

United States
National Cancer Institute (NCI)

Completed

A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Withdrawn

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Glioma | Pinealoma | Brain Stem Neoplasms
National Cancer Institute (NCI)

Completed

Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods

Calibration

United States
National Cancer Institute (NCI)

Completed

Pilots of Self-Collection for HPV DNA Detection

HPV

United States
National Cancer Institute (NCI)

Completed

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

Follicular Lymphoma | B Cell Lymphoma | Neoplasm

United States
National Cancer Institute (NCI)

Completed

Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Low-Cost Molecular Cervical Cancer Screening Study

Uterine Cervical Neoplasms | HPV | DNA Probes | E6 Protein

United States, China
National Cancer Institute (NCI)

Completed

Collection of Blood, Bone Marrow, Tumor or Tissue Samples

Neoplasms | Precancerous Conditions

United States
National Cancer Institute (NCI)

Completed

Exercise in Women at Risk for Breast Cancer

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Evaluating Serum Sex Steroid Hormones

Validation

United States
National Cancer Institute (NCI)

Completed

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

Hepatitis C Virus

United States
National Cancer Institute (NCI)

Completed

Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)

Cancer

United States
National Cancer Institute (NCI)

Completed

Relationship of pAKT to Survival in Patients With Node-Positive Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks

Environment

United States
National Cancer Institute (NCI)

Completed

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1

Human T-Lymphoma Virus Type I

United States, Jamaica, Japan
National Cancer Institute (NCI)

Completed

Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)

Leukocyte Adhesion Deficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis

HTLV-I

Jamaica
National Cancer Institute (NCI)

Terminated

UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas

Lymphoma, T-Cell | Lymphoma, Large-Cell, Ki-1

United States
National Cancer Institute (NCI)

Terminated

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Gastrointestinal Neoplasms | Ovarian Neoplasms | Ovarian Cancer | Ascites | Gastrointestinal Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)

Solid Tumor | Anaplastic Thyroid Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Intraocular Melanoma | Malignant Conjunctival Neoplasm

United States
National Cancer Institute (NCI)

Completed

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

Brain Tumors | High Grade Gliomas

United States

Clinical Trials Sponsored by National Cancer Institute, Lithuania

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations